Home › Pagkabigo ng Bato › Arizona
Pag-aaral pangklinika para sa Pagkabigo ng Bato sa Arizona
6 pag-aaral para sa Pagkabigo ng Bato ang naghahanap ng mga kalahok sa mga site sa Arizona.
Mga Lungsod sa Arizona
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function
- Arizona Clinical Trials - Chandler, Chandler
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 84 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07763418Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- AKDHC Medical, Glendale
- Kidney Disease Medical Group, Glendale
- AKDHC Medical, Phoenix
- at 2 pa
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05485961REgulatory T Cell Therapy to Achieve Immunosuppression REduction
- Mayo Clinic in Arizona, Phoenix
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Abr 27, 2026 · NCT06552169Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
- Southwest Kidney Institute, Phoenix
- AKDHC Medical Research Services, Phoenix
- AKDHC Center Tucson, Tucson
Nagre-recruit
Edad 18 hanggang 84 · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT06190717SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- AKDHC Bullhead City, Bullhead City
- AKDHC Marana Surgery Center, Marana
- Arizona Kidney Disease & Hypertension Centers (AKDHC) Phoenix Surgery Center, Phoenix
- at 1 pa
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 17, 2026 · NCT06001827A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- AKDHC Medical Research Services, LLC, Phoenix
Nagre-recruit
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Dis 22, 2025 · NCT04671771Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.